Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Mcg Bleeker"'
Publikováno v:
Cervical cancer.
Introduction/Background* According to the 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system, cervical cancer with ≤5 mm depth of invasion (DOI) and >7 mm horizontal spread, first classified as FIGO stage IB, are now c
Autor:
Rdm Steenbergen, AP Van Splunter, N van Trommel, Bmm Wever, Jenneke C Kasius, R Van den Helder, Constantijne H. Mom, Mcg Bleeker
Publikováno v:
Endometrial cancer.
Introduction/Background* Urine may offer an alternative sample type for gynecologic cancer detection1, which is easily accessible and allows self-sampling at home. DNA methylation is an emerging biomarker for early cancer detection, and the feasibili
Autor:
Mcg Bleeker, AP Van Splunter, MY Tjiong, Iam Van der Avoort, I Martins, Rdm Steenbergen, N van Trommel, F Rosier-van Dunné, R Van den Helder, Constantijne H. Mom
Publikováno v:
Cervical cancer.
Introduction/Background* Urine, as a liquid biopsy, can be obtained easily and noninvasively. Urine sampling might increase effectiveness of cervical cancer screening programs, by attracting women currently unreached by conventional screening methods
Publikováno v:
Poster exhibition Day 2.
Introduction/Background Vulvar intraepithelial neoplasia’s (VIN) comprise a heterogeneous disease entity and have an ambiguous vulvar squamous cancer (VSCC) risk. Human Papillomavirus (HPV) associated VIN accounts for more than 90% of all high-grad
Autor:
M van Beurden, Rdm Steenbergen, Dam Heideman, Nikki B Thuijs, Dra Swarts, AP Van Splunter, S. Duin, J. Berkhof, Mcg Bleeker
Publikováno v:
Poster exhibition Day 2.
Introduction/Background High-grade vulvar intraepithelial neoplasia (VIN) is the precancerous state of vulvar squamous cell carcinoma (VSCC). Vulvar carcinogenesis is a heterogeneous disease with only a minority of VINs progressing to cancer. Because
Autor:
Birgit I. Lissenberg-Witte, Renske D.M. Steenbergen, Daniëlle A M Heideman, Albert G. Siebers, Mcg Bleeker, Frederique J Vink, J. Berkhof, F. J. van Kemenade, C. J. L. M. Meijer
Publikováno v:
Clinical Microbiological and Infection, 27(1), 125.e1-125.e6
Clinical Microbiology and Infection, 27(1), 125.e1-125.e6. Elsevier Ltd.
Vink, F J, Lissenberg-Witte, B I, Meijer, C J L M, Berkhof, J, van Kemenade, F J, Siebers, A G, Steenbergen, R D M, Bleeker, M C G & Heideman, D A M 2021, ' FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women : cross-sectional and longitudinal data from a Dutch screening cohort ', Clinical Microbiological and Infection, vol. 27, no. 1, pp. 125.e1-125.e6 . https://doi.org/10.1016/j.cmi.2020.03.018
Clinical Microbiology and Infection, 27(1), 125.e1-125.e6. Elsevier Ltd.
Vink, F J, Lissenberg-Witte, B I, Meijer, C J L M, Berkhof, J, van Kemenade, F J, Siebers, A G, Steenbergen, R D M, Bleeker, M C G & Heideman, D A M 2021, ' FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women : cross-sectional and longitudinal data from a Dutch screening cohort ', Clinical Microbiological and Infection, vol. 27, no. 1, pp. 125.e1-125.e6 . https://doi.org/10.1016/j.cmi.2020.03.018
OBJECTIVES: The aim was to evaluate the cross-sectional and long-term triage performance of FAM19A4/miR124-2 methylation analysis in human papillomavirus (HPV)-based cervical screening.METHODS: We conducted a post hoc analysis within a Dutch populati
Autor:
Jbg Halfwerk, Saara Bryk, S Kommoss, Noora Andersson, Gkj Hooijer, Leila Unkila-Kallio, HS van Meurs, Hugo M. Horlings, G.G. Kenter, M.J. van de Vijver, Anniina Färkkilä, Buist, Aline Talhouk, Mikko Anttonen, Ralf Bützow, Annette Staebler, Winnie Yang, CB Gilks, K Zaby, Sara Y. Brucker, Markku Heikinheimo, Mcg Bleeker, David G. Huntsman, Melissa K. McConechy, Nirit Rozenberg, Bernhard Kraemer
Publikováno v:
Geburtshilfe und Frauenheilkunde. 76
Hintergrund: Die histopathologische Diagnostik adulter Granulosazelltumoren (aGCT) beruht auf der Begutachtung morphologischer und immunhistochemischer Kriterien. Aufgrund bislang nicht verfugbarer tumorspezifischer Marker kann die Begutachtung entsp
Autor:
Voss FO; Amsterdam UMC location Vrije Universiteit Amsterdam, Pathology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Berkhof J; Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, The Netherlands., Duin S; Amsterdam UMC location Vrije Universiteit Amsterdam, Pathology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Fons G; Amsterdam UMC location Vrije Universiteit Amsterdam, Gynecology, Amsterdam, The Netherlands., van Beurden M; Netherlands Cancer Institute/Antoni Van Leeuwenhoek Hospital, Gynecology, Amsterdam, The Netherlands., Steenbergen RDM; Amsterdam UMC location Vrije Universiteit Amsterdam, Pathology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands., Bleeker MCG; Amsterdam UMC location Vrije Universiteit Amsterdam, Pathology, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands. Electronic address: mcg.bleeker@amsterdamumc.nl.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Sep; Vol. 37 (9), pp. 100553. Date of Electronic Publication: 2024 Jun 24.
Autor:
Bleeker MCG, Bosse T, van de Vijver KK, Bart J, Horlings H, Jonges TGN, Visser NCM, Kooreman LFS, Bulten J, Ewing-Graham PC
Publikováno v:
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists [Int J Gynecol Pathol] 2024 Sep 01; Vol. 43 (5), pp. 457-463. Date of Electronic Publication: 2024 Feb 02.
Autor:
Schaafsma M; Department of Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Biomarkers and Imaging, Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Helder R; Department of Gynecology, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands.; Department of Gynecology, Zaans Medisch Centrum, Zaandam, The Netherlands., Mom CH; Department of Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Steenbergen RDM; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Biomarkers and Imaging, Cancer Center Amsterdam, Amsterdam, The Netherlands., Bleeker MCG; Department of Pathology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Biomarkers and Imaging, Cancer Center Amsterdam, Amsterdam, The Netherlands., van Trommel NE; Department of Gynecologic Oncology, Center of Gynecologic Oncology Amsterdam, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Aug 22. Date of Electronic Publication: 2024 Aug 22.